Xilio Therapeutics, Inc. (XLO)
8.30
-0.05
(-0.60%)
USD |
NASDAQ |
May 27, 16:00
8.30
0.00 (0.00%)
After-Hours: 18:43
Xilio Therapeutics Cash from Investing (Quarterly) : -0.556M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Verastem, Inc. | -16.02M |
| Opus Genetics, Inc. | 0.00 |
| Sensei Biotherapeutics, Inc. | 1.743M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.34M |
| Cash from Financing (Quarterly) | 35.71M |
| Free Cash Flow | -57.36M |
| Free Cash Flow Per Share (Quarterly) | -1.401 |
| Free Cash Flow to Equity (Quarterly) | -22.58M |
| Free Cash Flow to Firm (Quarterly) | -22.90M |
| Free Cash Flow Yield | -59.64% |